Are you Dr. Lowe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Val Lowe, MD is a board certified nuclear medicine physician in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Florida, and Georgia. He is affiliated with Mayo Clinic Hospital - Rochester and is a Professor at Mayo Medical School.
Education & Training
- Duke University HospitalResidency, Nuclear Medicine, 1991 - 1994
- LDS HospitalResidency, Internal Medicine, 1988 - 1991
- McGill University Faculty of MedicineClass of 1988
Certifications & Licensure
- AZ State Medical License 2001 - 2026
- UT State Medical License 1989 - 2026
- FL State Medical License 2013 - 2025
- MN State Medical License 1999 - 2025
- WI State Medical License 2013 - 2025
- IA State Medical License 2013 - 2023
- GA State Medical License 2013 - 2016
- American Board of Nuclear Medicine Nuclear Medicine
- Join now to see all
Clinical Trials
- Everolimus in Treating Patients With Stage IV Melanoma Start of enrollment: 2005 Apr 01
- Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
- Imaging of Brain Amyloid Plaques in the Aging Population Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citations1 H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adultsZuzana Nedelska, Scott A. Przybelski, Timothy G. Lesnick, Christopher G. Schwarz, Val J. Lowe
Neurology. 2017-09-26 - 15 citationsRelationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease.Jennifer L. Whitwell, Nirubol Tosakulwong, Stephen D. Weigand, Jonathan Graff-Radford, Nilufer Ertekin-Taner
Neurobiology of Aging. 2021-08-25 - 364 citationsAn autoradiographic evaluation of AV-1451 Tau PET in dementia.Val J. Lowe, Geoffry L. Curran, Ping Fang, Amanda M. Liesinger, Keith A. Josephs
Acta Neuropathologica Communications. 2016-06-13
Press Mentions
- Meet Mukesh Pandey, Ph.D. – Developing a New Drug to Detect Prostate Cancer in Its Earliest StagesSeptember 23rd, 2019
- Surgical Planning for Head and Neck Cancer Benefits from FDG-PET/CTAugust 7th, 2019
- Game Changers: Five Innovative Tests for Cancer DetectionSeptember 21st, 2017
- Join now to see all